JENNINGS GODSY: Open Payments
NPI 1174726996 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 84 payments from 15 companies in 2025. Trend: 2023 $620 · 2024 $119 · 2025 $1,160
Food & beverage: $1,134Education: $26
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $179 |
| ABBVIE INC. | 15 | $164 |
| Neurocrine BioSciences, Inc. | 14 | $159 |
| Alkermes, Inc. | 14 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $137 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Tempus AI, Inc | 2 | $53 |
| Supernus Pharmaceuticals, Inc. | 3 | $42 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, LYBALVI, TRINTELLIX, Auvelity, SPRAVATO, TEMPUS PIXEL.
Industry payments across TX — which companies pay providers there.
